Nirmatrelvir/ritonavir (redirect from Paxlovid) Nirmatrelvir/ritonavir, sold under the brand name Paxlovid, is a co-packaged medication used as a treatment for COVID‑19. It contains the antiviral medications... 64 KB (5,751 words) - 07:52, 24 March 2024 |
oral antiviral Paxlovid". Pharmaceutical Technology. Archived from the original on 18 December 2021. Retrieved 18 December 2021. "Paxlovid LOA 12222021... 372 KB (32,316 words) - 04:26, 25 April 2024 |
with COVID-19 treated with Paxlovid were published. In May, CDC even issued a health alert informing physicians about "Paxlovid rebounds", which received... 11 KB (1,263 words) - 16:06, 16 August 2023 |
who are in the risk groups can take nirmatrelvir/ritonavir (marketed as Paxlovid) or remdesivir, either of which reduces the risk of serious illness or... 285 KB (32,669 words) - 05:08, 20 April 2024 |